Wosulin-N 40IU/ml Suspension for Injection

Short Description

Wosulin-N 40IU/ml Suspension for Injection is used to improve blood sugar control in adults and children with type 1 and type 2 diabetes mellitus.

Dosage Form

Suspension for Injection

Introduction

Wosulin-N 40IU/ml Suspension for Injection is often prescribed along with short-acting insulin or other oral diabetes medicines. Your doctor or nurse will teach you the correct way of injecting it under the skin. Don’t stop taking it unless your doctor tells you to. It is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Check your blood sugar levels regularly, keep track of your results, and share them with your doctor. This is very important to work out the correct dose of the medicine for you.

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

Side Effects

Hypoglycemia (low blood sugar level), reactions at the injection site like redness or swelling, lipodystrophy (skin thickening or pits at the injection site), weight gain, edema (swelling over the whole body due to fluid retention)

Alcohol Warning

It is unsafe to consume alcohol with Wosulin-N 40IU/ml Suspension for Injection.

Breastfeeding Warning

Wosulin-N 40IU/ml Suspension for Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.

Pregnancy Warning

Wosulin-N 40IU/ml Suspension for Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Interacting Medicines

Benazepril Captopril Enalapril Fosinopril

Wosulin-N 40IU/ml Suspension for Injection is an intermediate-acting insulin that starts working in 1-2 hours after injection. It works similar to the insulin that is produced by the body. Insulin facilitates reuptake of sugar in muscle and fat cells and also suppresses the production of sugar in the liver. This helps to lower the blood sugar levels in diabetes mellitus.

Hypoglycemia (low blood sugar level) is a common side effect. Hence regular monitoring of blood sugar levels is required while taking this medicine. Injection below the skin of the abdomen results in faster absorption than other injection sites. Injection sites must be rotated to prevent hard lumps from developing at one site. Opened vials/cartridges are good at room temperature for up to 4 weeks while unopened vials must be placed in the refrigerator (2°C–8°C).